TipRanks
KALA BIO (DE:27F)
FRANKFURT:27F
Germany Market
27F
KALA BIO
RESEARCH TOOLSreports

KALA BIO (27F) Income Statement

0 Followers

KALA BIO Income Statement

Last quarter (Q2 2026), KALA BIO's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, KALA BIO's net income was $-1.58M. See KALA BIO’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 3.89M$ 11.24M
Gross Profit
$ 0.00$ -259.00K$ -303.00K$ 1.33M$ 7.14M
Operating Expenses
$ 39.16M$ 40.17M$ 38.85M$ 82.69M$ 116.58M
Depreciation and Amortization
$ 317.00K$ 259.00K$ 303.00K$ 860.00K$ 2.27M
EBITDA
$ -23.39M$ -32.47M$ -36.08M$ -36.70M$ -131.96M
Operating Income
$ -39.16M$ -40.43M$ -39.15M$ -81.36M$ -109.43M
Other Income/Expenses
$ 12.18M$ 1.92M$ -3.05M$ 36.53M$ -33.17M
Pretax Income
$ -26.98M$ -38.51M$ -42.20M$ -44.82M$ -142.60M
Net Income
$ -26.98M$ -38.51M$ -42.20M$ -44.82M$ -142.60M
Per Share Metrics
Basic EPS
$ -165.50$ -507.50$ -867.50$ -1.47K$ -108.32
Diluted EPS
$ -165.50$ -507.50$ -867.50$ -1.47K$ -108.32
Weighted Average Shares Outstanding
 162.97K 75.92K 48.64K 30.41K 1.32M
Weighted Average Shares Outstanding (Diluted)
 162.97K 75.92K 48.64K 30.41K 1.32M
Currency in USD

KALA BIO Earnings and Revenue History